JOURNEY MEDICAL (DERM)

$5.26 0.37 (7.03%)

19:00 EST DERM Stock Quote Delayed 30 Minutes

DERM Stock Earnings: Journey Medical Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings Aug 12, 2024

DERM stock results show that Journey Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

DERM Stock Earnings: Journey Medical Beats EPS, Misses Revenue for Q1 2024

DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Volume:

Previous Close $5.58

Market Cap 117.61M

PE Ratio -5.48

EPS -0.9605

Volume (Avg. Vol.) 48,388

Day's Range $5.33 - $5.71

52-Week Range $2.85 - $6.89

Dividend & Yield N/A (N/A)

DERM Stock Predictions, Articles, and JOURNEY MEDICAL News

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 8, 2023

Pre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning!

7 Investing Resolutions to Follow in 2020

By Chris Lau, InvestorPlace Contributor Jan 6, 2020

While you're going to the gym and starting a diet, why not make some investing resolutions? Try to avoid fad stocks and demand dividends.

5 Growthy Biotech Stocks to Buy Despite the Scrutiny

By Chris Lau, InvestorPlace Contributor May 13, 2019

Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?

Dermira News: Why DERM Stock Is Skyrocketing Today

By William White, InvestorPlace Writer Mar 18, 2019

Dermira news concerning positive results from a recent Phase 2b study of lebrikizumab has DERM stock flying high on Monday.

5 Big Biotech Stocks to Buy Under $10

By Aaron Levitt, InvestorPlace Contributor Mar 20, 2018

Small biotech stocks can pack a wallop. Here are five biotech stocks that have prospects bigger than their share prices.

Dermira Inc Stock Plunges on Acne Drug Failure

By William White, InvestorPlace Writer Mar 5, 2018

Dermira (DERM) stock is tanking today on news that its new acne drug is a failure and that it will likely stop its development.

10 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Dec 23, 2016

This week, the overall grades of 10 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

10 Pharmaceuticals Stocks to Buy Now

By Portfolio Grader Oct 7, 2016

10 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

11 Pharmaceuticals Stocks to Buy Now

By Portfolio Grader Sep 30, 2016

The grades of 11 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Biggest Movers in Manufacturing Stocks Now – ACUR NVET AEPI SJM

By Portfolio Grader Jun 9, 2016

The following stocks were moving the Manufacturing sector today.

3 Stocks to Watch on Thursday: Ciena Corporation (CIEN), Dermira Inc (DERM) and Joy Global Inc. (JOY)

By Karl Utermohlen, InvestorPlace Writer Jun 2, 2016

Ciena (CIEN) and Joy Global (JOY) shoot higher on Street-beating results, while Dermira (DERM) is popping on positive trial news for its sweating treatment.

Biggest Movers in Manufacturing Stocks Now – CCXI CROX NLS DERM

By Portfolio Grader May 10, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

3 Biotech Stocks You’ll Love Betting Against: FPRX, DERM, AGTC

By Profit Scanner Feb 19, 2016

Bearish investors can find an opportunity in these biotech stocks as they look to continue a downward trend.

JOURNEY MEDICAL (DERM)

DERM Stock Earnings: Journey Medical Misses EPS, Beats Revenue for Q2 2024

DERM Stock Earnings: Journey Medical Beats EPS, Misses Revenue for Q1 2024

DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

JOURNEY MEDICAL (DERM)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

DERM Stock Predictions, Articles, and JOURNEY MEDICAL News

Subscriber Sign in